JOURNAL OF MOLECULAR MODELING, published by Springer, is a pivotal resource for researchers and professionals in the fields of chemistry, computer science, and molecular sciences. The journal's ISSN is 1610-2940, with an E-ISSN of 0948-5023, reflecting its commitment to disseminating cutting-edge research from 1996 to 2024. Although the journal does not operate under an Open Access model, it remains an invaluable platform for the publication of innovative studies related to computational methods, theoretical chemistry, and molecular simulations. With a notable categorization across multiple quartiles—including Q4 in Catalysis and Q3 in Computational Theory and Mathematics—the journal holds a distinct rank in Scopus, highlighting its influence and contribution to the discipline. The importance of this journal lies in its ability to bridge the gap between theoretical understanding and practical applications, making it essential reading for students and scholars seeking to advance their knowledge and research in molecular modeling.

MOLECULAR SIMULATION, published by TAYLOR & FRANCIS LTD, stands as a pivotal platform in the interdisciplinary landscape of molecular modeling and simulation, bridging the fields of chemistry, physics, and materials science. Since its inception in 1987, this journal has been dedicated to publishing high-quality research that advances the understanding of complex molecular systems. With a variety of articles covering innovative computational methods and their applications across diverse domains, it resonates well with both established researchers and emerging scholars. Although currently not an open access journal, it maintains a respectable presence within the academic community, illustrated by its Q3 quartile rankings in key categories such as Chemical Engineering, Condensed Matter Physics, and Information Systems as of 2023. Further, its Scopus rankings position it favorably within the respective fields, making it an essential resource for anyone interested in the quantitative aspects of molecular research. With its comprehensive scope, MOLECULAR SIMULATION continues to foster collaboration and innovation, helping to bridge theoretical research with practical applications.

COMPUTATIONAL BIOLOGY AND CHEMISTRY is a distinguished academic journal published by Elsevier Science Ltd, focusing on the dynamic intersection of computational biology, biochemistry, and chemistry. With an ISSN of 1476-9271 and an E-ISSN of 1476-928X, this journal is committed to disseminating high-quality research that employs computational techniques to solve complex biological and chemical problems. As of 2023, the journal holds a substantial impact factor reflecting its significance and rigorous peer-review process, categorized in the Q2 quartile for both Computational Mathematics and Organic Chemistry, alongside Q3 classifications in Biochemistry and Structural Biology. With a continuous publication history spanning from 2003 to 2024, it serves as a critical resource for researchers, professionals, and students alike. The journal offers various open access options, ensuring that vital research findings are accessible to a global audience, further enhancing collaboration across disciplines. Engage with cutting-edge studies and contribute to the evolving landscape of computational methodologies in the life sciences through this esteemed publication.

JOURNAL OF MOLECULAR RECOGNITION, published by Wiley, is an esteemed academic journal that has been at the forefront of molecular biology and structural biology research since its inception in 1988. With its ISSN 0952-3499 and E-ISSN 1099-1352, this journal serves as a vital platform for disseminating innovative studies and findings in the realms of biochemical interactions and molecular structure elucidation. Although currently positioned in Quartile 4 of both molecular and structural biology categories based on 2023 metrics, the journal is dedicated to advancing knowledge in quantitative and qualitative molecular recognition processes. Researchers, professionals, and students alike will find that this journal is instrumental in keeping abreast of cutting-edge developments in the field, even as it continues to build its impact and reputation within the dynamic research landscape. Located in the United Kingdom, it is committed to promoting a diverse range of studies that drive forward the understanding of molecular interaction phenomena, thus empowering its readership to contribute effectively to the field.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, published by TAYLOR & FRANCIS INC, serves as a pivotal platform for the dissemination of original research in the fields of biochemistry, molecular biology, and structural biology. With an ISSN of 0739-1102 and an E-ISSN of 1538-0254, this esteemed journal has garnered attention for its rigorous peer-review process and commitment to high-quality scientific inquiry since its inception in 1981. Ranking in the Q2 quartile for miscellaneous medicine and the Q3 quartile for both molecular and structural biology, it consistently demonstrates a significant impact within its specialties, evidenced by a high Scopus ranking. Researchers, professionals, and students are encouraged to engage with cutting-edge studies addressing the complex interactions and dynamics of biomolecules, making this journal a vital resource for advancing knowledge in the biological sciences. Although it does not offer open access options, its valuable contributions are vital for the ongoing discourse within the scientific community.

Chemical Biology & Drug Design, an esteemed publication by WILEY, serves as a vital platform for the dissemination of pioneering research in the interdisciplinary fields of biochemistry, drug discovery, molecular medicine, organic chemistry, and pharmacology. With a dedicated commitment to advancing the understanding of chemical interactions and drug development, this journal not only fosters innovation but also bridges the gap between theoretical research and practical applications. It boasts an impressive impact factor and is recognized in the 2023 category quartiles as Q3 in Biochemistry and Molecular Medicine, and Q2 in Drug Discovery, Organic Chemistry, and Pharmacology, indicating its relevance and influence in these crucial areas. The journal’s rankings across various Scopus categories further solidify its position as a reputable resource for researchers, professionals, and students striving to stay at the forefront of medicinal chemistry and drug design. While primarily traditional access-based, the journal's evolving scope from 2006 to 2024 ensures an ongoing contribution to essential scientific dialogue, making it an indispensable read for those committed to advancing health sciences.

JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, published by TAYLOR & FRANCIS LTD, is a premier academic journal dedicated to advancing our understanding of receptor biology and signal transduction mechanisms. With an ISSN of 1079-9893 and an E-ISSN of 1532-4281, this journal has maintained a reputable standing since its inception in 1980, continually addressing pivotal topics in biochemistry, cell biology, and molecular biology. As evidenced by its 2023 Scopus rankings, which place it in the 64th percentile for Biochemistry and Genetics and Molecular Biology, JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION remains a vital source for cutting-edge research, providing insights that are essential for both academic and practical applications. Although the journal currently offers limited open access options, it stands out in the Q2 and Q3 quartiles of its respective categories, making it an invaluable resource for researchers, professionals, and students aiming to stay abreast of the latest findings and methodologies in receptor and signaling research. The journal's commitment to disseminating high-quality research underscores its significance within the scientific community, fostering innovation and collaboration across disciplines.

Current Bioinformatics, an esteemed journal published by Bentham Science Publishers Ltd, serves as a pivotal platform for the dissemination of cutting-edge research in the fields of bioinformatics, biochemistry, computational mathematics, genetics, and molecular biology. With an ISSN of 1574-8936 and an E-ISSN of 2212-392X, this journal has established itself as a vital resource for researchers, professionals, and students keen on exploring interdisciplinary approaches to biological data analysis. Its prominence is reflected in its quartile rankings for 2023, where it stands in Q3 for biochemistry and computational mathematics, alongside Q4 rankings in genetics and molecular biology. Current Bioinformatics, located in the United Arab Emirates and converging from 2007 to 2024, aims to foster innovation in the field by presenting original research articles, reviews, and case studies that drive forward our understanding of complex biological systems through computational techniques. This journal is an integral resource for those wishing to stay at the forefront of bioinformatics research and applications.

Chem-Bio Informatics Journal is a dedicated platform for the dissemination of innovative research in the intersecting realms of biochemistry and computational science. Published by the CHEM-BIO INFORMATICS SOC in Japan, this journal embraces the rapidly evolving field of chemoinformatics and bioinformatics, fostering scholarly communication among researchers, professionals, and students alike. With its ISSN: 1347-6297 and E-ISSN: 1347-0442, the journal continues to enrich the scientific community by offering insights into novel methodologies and applications that bridge chemistry and biology. Although currently positioned in the fourth quartile in the biochemistry category according to Scopus rankings, contributing to this journal provides an invaluable opportunity for authors to showcase impactful findings that could resonate within the field. The journal is particularly committed to supporting interdisciplinary research that addresses complex biological problems through computational modeling and data analysis. By publishing high-quality and peer-reviewed articles, Chem-Bio Informatics Journal aims to enhance the scientific discourse and is poised to become a pivotal resource for advancing the frontiers of biochemistry and molecular biology.

Current Computer-Aided Drug Design, published by BENTHAM SCIENCE PUBL LTD, is a pivotal journal dedicated to the integration of computer-aided methodologies within the drug design process. With its ISSN 1573-4099 and E-ISSN 1875-6697, this journal serves as a vital resource for researchers, professionals, and students interested in advancing the fields of pharmacology and molecular medicine. Operating under a framework that spans from 2006 to 2024, it aims to foster innovative approaches and discussions surrounding drug design strategies, computational techniques, and the therapeutic potential of novel compounds. Although it currently holds a Q4 rating in Drug Discovery and Molecular Medicine as well as a Q3 in Medicine (miscellaneous) within the 2023 category quartiles, the journal continues to enhance its visibility and relevance in the academic community. Its Scopus rankings reflect its commitment to quality research, positioning it in the context of drug discovery and molecular studies. As the field of drug design evolves, Current Computer-Aided Drug Design remains an essential platform for disseminating cutting-edge findings and facilitating collaboration among specialists aiming for significant advancements in drug development.